Unity Biotechnology Inc. (UBX) NASDAQ
$0.59 -0.01 (-0.97%)
Market Cap: $41.10M
As of 06/24/22 04:00 PM EDT. Market closed.
Unity Biotechnology Inc. (UBX) NASDAQ
$0.59 -0.01 (-0.97%)
Market Cap: $41.10M
As of 06/24/22 04:00 PM EDT. Market closed.
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic ... read more
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Anirvan Ghosh
Full Time Employees
61
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$2.73M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Anirvan Ghosh
Full Time Employees
61
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$2.73M
Address
3280 Bayshore Blvd, California, Brisbane, 94005-1028.
PRICE CHART
From:
To:
NEWS
KEY STATS
Open
$0.60
Previous Close
$0.60
Days Range
$0.59 - $0.63
52 week range
$0.57 - $4.97
Volume
326,341
Avg. Volume (30 days)
413,182
Market Cap
$41.10M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
69,168,939
Open
$0.60
Previous Close
$0.60
Days Range
$0.59 - $0.63
52 week range
$0.57 - $4.97
Volume
326,341
Avg. Volume (30 days)
413,182
Market Cap
$41.10M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
69,168,939
Open in:
Open in:
INSIDER TRANSACTIONS FOR UNITY BIOTECHNOLOGY INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Dananberg Jamie | Chief Medical Officer | Jun 21, 2022 | Sale | $0.62 | 3,697 | 2,292 | 676,534 | Jun 22, 2022, 04:49 PM |
| Ghosh Anirvan | Chief Executive Officer | Jun 14, 2022 | Option Exercise | $0.63 | 12,683 | 7,990 | 1,019,511 | Jun 15, 2022, 04:36 PM |
| Dananberg Jamie | Chief Medical Officer | Jun 14, 2022 | Option Exercise | $0.63 | 10,530 | 6,634 | 680,231 | Jun 15, 2022, 04:34 PM |
| Ghosh Anirvan | Chief Executive Officer | May 02, 2022 | Option Exercise | $0.88 | 7,729 | 6,802 | 1,032,194 | May 03, 2022, 05:18 PM |
| Ghosh Anirvan | Chief Executive Officer | Mar 31, 2022 | Option Exercise | $1.14 | 14,472 | 16,498 | 1,039,923 | Apr 01, 2022, 04:24 PM |
| Dananberg Jamie | Chief Medical Officer | Mar 31, 2022 | Option Exercise | $1.14 | 4,188 | 4,774 | 690,761 | Apr 01, 2022, 04:24 PM |
| Ghosh Anirvan | Chief Executive Officer | Mar 14, 2022 | Option Exercise | $0.88 | 9,272 | 8,159 | 1,054,395 | Mar 15, 2022, 04:54 PM |
| Dananberg Jamie | Chief Medical Officer | Mar 14, 2022 | Option Exercise | $0.88 | 10,581 | 9,311 | 694,949 | Mar 15, 2022, 04:53 PM |
| Dananberg Jamie | Chief Medical Officer | Dec 14, 2021 | Option Exercise | $1.63 | 10,614 | 17,301 | 659,697 | Dec 15, 2021, 04:26 PM |
| Dananberg Jamie | Chief Medical Officer | Mar 30, 2021 | Option Exercise | $2.95 | 40,564 | 119,664 | 670,311 | Oct 01, 2021, 09:57 PM |
| Dananberg Jamie | Chief Medical Officer | Jun 21, 2021 | Option Exercise | $4.18 | 3,515 | 14,693 | 685,875 | Jun 23, 2021, 05:03 PM |
| Dananberg Jamie | Chief Medical Officer | Mar 30, 2021 | Option Exercise | $5.73 | 2,829 | 16,210 | 689,390 | Apr 01, 2021, 05:13 PM |
| David Nathaniel E | President | Dec 16, 2020 | Sale | $5.24 | 1,700,000 | 8,908,000 | 624,703 | Dec 18, 2020, 05:14 PM |
| Goeltz II Robert C. | Chief Financial Officer | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 161,027 | Jun 24, 2020, 05:03 PM |
| David Nathaniel E | President | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 2,324,703 | Jun 24, 2020, 05:00 PM |
| Marquess Dan | Chief Scientific Officer | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 380,690 | Jun 24, 2020, 04:59 PM |
| Dananberg Jamie | Chief Medical Officer | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 452,219 | Jun 24, 2020, 04:59 PM |
| Tompkins Tamara | See Remarks | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 42,847 | Jun 24, 2020, 04:58 PM |
| Leonard Keith R | Director | Jun 22, 2020 | Option Exercise | $9.67 | 4,711 | 45,555 | 89,546 | Jun 24, 2020, 04:58 PM |
| David Nathaniel E | President | Jun 05, 2020 | Buy | $8.90 | 3,200 | 28,478 | 2,327,186 | Jun 09, 2020, 04:44 PM |
| Goeltz II Robert C. | Chief Financial Officer | Feb 24, 2020 | Option Exercise | $3.43 | 10,000 | 34,300 | 134,404 | Feb 26, 2020, 05:48 PM |
| Leonard Keith R | Chief Executive Officer | Jun 19, 2019 | Option Exercise | $3.40 | 20,000 | 68,000 | 170,782 | Jun 19, 2019, 09:14 PM |
| Goeltz II Robert C. | Chief Financial Officer | Oct 10, 2018 | Option Exercise | $3.43 | 5,000 | 17,150 | 101,348 | Oct 12, 2018, 05:36 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Dananberg Jamie | Chief Medical Officer | 06/21/2022 | 2,292 |
| Ghosh Anirvan | Chief Executive Officer | 06/14/2022 | 7,990 |
| Dananberg Jamie | Chief Medical Officer | 06/14/2022 | 6,634 |
| Ghosh Anirvan | Chief Executive Officer | 05/02/2022 | 6,802 |
| Ghosh Anirvan | Chief Executive Officer | 03/31/2022 | 16,498 |
| Dananberg Jamie | Chief Medical Officer | 03/31/2022 | 4,774 |
| Ghosh Anirvan | Chief Executive Officer | 03/14/2022 | 8,159 |
| Dananberg Jamie | Chief Medical Officer | 03/14/2022 | 9,311 |
| Dananberg Jamie | Chief Medical Officer | 12/14/2021 | 17,301 |
| Dananberg Jamie | Chief Medical Officer | 03/30/2021 | 119,664 |
| Dananberg Jamie | Chief Medical Officer | 06/21/2021 | 14,693 |
| Dananberg Jamie | Chief Medical Officer | 03/30/2021 | 16,210 |
| David Nathaniel E | President | 12/16/2020 | 8,908,000 |
| Goeltz II Robert C. | Chief Financial Officer | 06/22/2020 | 24,011 |
| David Nathaniel E | President | 06/22/2020 | 24,011 |
| Marquess Dan | Chief Scientific Officer | 06/22/2020 | 24,011 |
| Dananberg Jamie | Chief Medical Officer | 06/22/2020 | 24,011 |
| Tompkins Tamara | See Remarks | 06/22/2020 | 24,011 |
| Leonard Keith R | Director | 06/22/2020 | 45,555 |
| David Nathaniel E | President | 06/05/2020 | 28,478 |
| Goeltz II Robert C. | Chief Financial Officer | 02/24/2020 | 34,300 |
| Leonard Keith R | Chief Executive Officer | 06/19/2019 | 68,000 |
| Goeltz II Robert C. | Chief Financial Officer | 10/10/2018 | 17,150 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2021
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2021
1.80%
1Q
06/30/2021
2.38%
2Q
03/31/2021
3.04%
3Q
12/31/2020
9.73%
4Q
09/30/2020
11.80%
5Q
06/30/2020
14.83%
6Q
12/31/2019
27.95%
8Q
09/30/2019
31.07%
9Q
03/31/2019
32.30%
11Q
Load More